Neuropsychopharmacology Reviews



Neurocircuitry: A Window into the Networks Underlying Neuropsychiatric Disease

Suzanne N Haber and Scott L Rauch

Neuropsychopharmacology 35: 1-3; doi:10.1038/npp.2009.146



The Reward Circuit: Linking Primate Anatomy and Human Imaging

Suzanne N Haber and Brian Knutson

Neuropsychopharmacology 35: 4-26; advance online publication, October 7, 2009; doi:10.1038/npp.2009.129

Cortico-Basal Ganglia Reward Network: Microcircuitry

Susan R Sesack and Anthony A Grace

Neuropsychopharmacology 35: 27-47; advance online publication, August 12, 2009; doi:10.1038/npp.2009.93

Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual Action

Bernard W Balleine and John P O'Doherty

Neuropsychopharmacology 35: 48-69; advance online publication, September 23, 2009; doi:10.1038/npp.2009.131

The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease

Sandra E Leh, Michael Petrides and Antonio P Strafella

Neuropsychopharmacology 35: 70-85; advance online publication, August 5, 2009; doi:10.1038/npp.2009.88

The Episodic Memory System: Neurocircuitry and Disorders

Bradford C Dickerson and Howard Eichenbaum

Neuropsychopharmacology 35: 86-104; advance online publication, September 23, 2009; doi:10.1038/npp.2009.126

Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety

Michael Davis, David L Walker, Leigh Miles and Christian Grillon

Neuropsychopharmacology 35: 105-135; advance online publication, August 19, 2009; doi:10.1038/npp.2009.109

Changing Fear: The Neurocircuitry of Emotion Regulation

Catherine A Hartley and Elizabeth A Phelps

Neuropsychopharmacology 35: 136-146; advance online publication, August 26, 2009; doi:10.1038/npp.2009.121

Normal Development of Brain Circuits

Gregory Z Tau and Bradley S Peterson

Neuropsychopharmacology 35: 147-168; advance online publication, September 30, 2009; doi:10.1038/npp.2009.115

The Neurocircuitry of Fear, Stress, and Anxiety Disorders

Lisa M Shin and Israel Liberzon

Neuropsychopharmacology 35: 169-191; advance online publication, July 22, 2009; doi:10.1038/npp.2009.83

Neurocircuitry of Mood Disorders

Joseph L Price and Wayne C Drevets

Neuropsychopharmacology 35: 192-216; advance online publication, August 19, 2009; doi:10.1038/npp.2009.104

Neurocircuitry of Addiction

George F Koob and Nora D Volkow

Neuropsychopharmacology 35: 217-238; advance online publication, August 26, 2009; doi:10.1038/npp.2009.110

Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules

Francine M Benes

Neuropsychopharmacology 35: 239-257; advance online publication, September 2, 2009; doi:10.1038/npp.2009.116

Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia

Daniel Paul Eisenberg and Karen Faith Berman

Neuropsychopharmacology 35: 258-277; advance online publication, August 19, 2009; doi:10.1038/npp.2009.111

Attention-Deficit/Hyperactivity Disorder and Attention Networks

George Bush

Neuropsychopharmacology 35: 278-300; advance online publication, September 16, 2009; doi:10.1038/npp.2009.120

Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)

Mark S George and Gary Aston-Jones

Neuropsychopharmacology 35: 301-316; advance online publication, August 19, 2009; doi:10.1038/npp.2009.87

Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD

Benjamin D Greenberg, Scott L Rauch and Suzanne N Haber

Neuropsychopharmacology 35: 317-336; advance online publication, September 16, 2009; doi:10.1038/npp.2009.128


Hot Topics

The role of the ventral pallidum in psychiatric disorders

T Celeste Napier and Amanda L Mickiewicz

Neuropsychopharmacology 35: 337; doi:10.1038/npp.2009.113

Exploring the molecular basis of addiction: drug-induced neuroadaptations

Jose A Morón and Thomas A Green

Neuropsychopharmacology 35: 337-338; doi:10.1038/npp.2009.106

The emerging role of integrins in neuropsychiatric disorders

Ana M D Carneiro

Neuropsychopharmacology 35: 338-339; doi:10.1038/npp.2009.134

Imaging advances in developing new medications for addiction

Frederick Gerard Moeller, Kimberly L Kjome and Liangsuo Ma

Neuropsychopharmacology 35: 339-340; doi:10.1038/npp.2009.98

Sex-related functional asymmetry in the limbic brain

Timothy Koscik, Antoine Bechara and Daniel Tranel

Neuropsychopharmacology 35: 340-341; doi:10.1038/npp.2009.122

Dissecting the neural circuitry of addiction and psychiatric disease with optogenetics

Garret D Stuber

Neuropsychopharmacology 35: 341-342; doi:10.1038/npp.2009.102


Narayanan Kasthuri and Jeff W Lichtman

Neuropsychopharmacology 35: 342-343; doi:10.1038/npp.2009.138

Modafinil: an anti-relapse medication

Pouya Tahsili-Fahadan, Robert Malcolm and Gary Aston-Jones

Neuropsychopharmacology 35: 343-344; doi:10.1038/npp.2009.123

Trick or treat? neurodevelopmental consequences of pharmacotherapy for affective disorders

Douglas O Frost, Robbin Gibb and Bryan Kolb

Neuropsychopharmacology 35: 344-345; doi:10.1038/npp.2009.133

Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery

Richard B Mailman and Vishakantha Murthy

Neuropsychopharmacology 35: 345-346; doi:10.1038/npp.2009.117

Induced pluripotent stem (iPS) cells and their future in psychiatry

Kwang-Soo Kim

Neuropsychopharmacology 35: 346-348; doi:10.1038/npp.2009.108

Advances in PET analyses of stress and dopamine

Romina Mizrahi

Neuropsychopharmacology 35: 348-349; doi:10.1038/npp.2009.132

Imaging and genetics advances in understanding geriatric depression

David C Steffens

Neuropsychopharmacology 35: 349-350; doi:10.1038/npp.2009.135

Neuronal signaling pathways: genetic insights into the pathophysiology of major mental illness

Russell L Margolis and Christopher A Ross

Neuropsychopharmacology 35: 350-351; doi:10.1038/npp.2009.137

Antidepressants, age, and neuroprogenitors

Maura Boldrini and Victoria Arango

Neuropsychopharmacology 35: 351-352; doi:10.1038/npp.2009.130

Normalizing drug-induced neuronal plasticity in nucleus accumbens weakens enduring drug-seeking behavior

Wenhua Zhou

Neuropsychopharmacology 35: 352-353; doi:10.1038/npp.2009.97

Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential

Stephanie L Borgland and Gwenaël Labouèbe

Neuropsychopharmacology 35: 353-354; doi:10.1038/npp.2009.119

New vaccine development for chronic brain disease

Alan DT Barrett, Rakez Kayed, George R Jackson and Kathryn A Cunningham

Neuropsychopharmacology 35: 354; doi:10.1038/npp.2009.147

Convergent Functional Genomics: what we have learned and can learn about genes, pathways, and mechanisms

Alexander B Niculescu and Helen Le-Niculescu

Neuropsychopharmacology 35: 355-356; doi:10.1038/npp.2009.107

Main navigation

ACNP resources

NPG resources

Extra navigation

21 November 2019